LawPlayer
My bookmarks
Source

2014/423/EU: Commission Implementing Decision of 1 July 2014 authorising the placing on the market of citicoline as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2014) 4252)

2014/423/EU: Commission Implementing Decision of 1 July 2014 authorising the placing on the market of citicoline as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2014) 4252)

Regulation (EC) No 258/97 · Decision · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Citicoline as specified in the Annex may be placed on the market in the Union as a novel food ingredient in food supplements with a maximum dose of 500 mg per day and in dietary foods for special medical purposes with a maximum dose of 250 mg per serving and with a maximum daily consumption level of 1 000 mg from these types of foods without prejudice to Directive 1999/21/EC and Directive 2002/46/EC. Citicoline shall not be used in foods intended to be consumed by children.

Article 2

Open ↗

The designation of citicoline authorised by this Decision on the labelling of the foodstuffs containing it shall be ‘citicoline’.

Article 3

Open ↗

Information shall be given to the consumer that foods containing citicoline are not intended to be consumed by children.

Article 4

Open ↗

This Decision is addressed to Kyowa Hakko Europe GmbH, Am Wehrhahn 50, 40211 Düsseldorf, Germany.

Supplementary provisions

SPECIFICATION OF CITICOLINE

ANNEXSupplementary provisions

Open ↗

ANNEX SPECIFICATION OF CITICOLINE Definition : Citicoline is composed of cytosine, ribose, pyrophosphate and choline. Chemical name: Choline cytidine 5′-pyrophosphate, Cytidine 5′-(trihydrogen diphosphate) P′-[2-(trimethylammonio)ethyl]ester inner salt Chemical formula: C 14 H 26 N 4 O 11 P 2 Molecular weight: 488,32 g/mol Description : White crystalline powder. Identification : CAS No 987-78-0 pH (sample solution of 1 %) 2,5-3,5 Purity : Assay value Not less than 98 % of dry matter Loss on drying (100 °C for 4 hours) Not more than 5,0 % Ammonium Not more than 0,05 % Total heavy metals (as Pb) Not more than 10 ppm Arsenic Not more than 2 ppm Free phosphoric acids Not more than 0,1 % 5′-Cytidylic acid Not more than 1,0 % Microbiological criteria : Total plate count Not more than 1 000 cfu/g Yeast and moulds Not more than 100 cfu/g Escherichia coli Absent in 1 g

Other acts of the same type
Commission Decision (EU) 2017/1592 of 15 May 2017 on the measure SA.35429 — 2017/C (ex 2013/NN) implemented by Portugal for the extension of use of public water resources for hydro-electricity generation (notified under document C(2017) 3110) (Text with EEA relevance. )Council Decision (EU) 2017/817 of 11 May 2017 establishing the position to be taken on behalf of the European Union within the World Trade Organisation on the modification of paragraph C(ii) of Annex 3 to the WTO Agreement as regards the frequency of WTO Trade Policy Reviews and of the rules of procedure of the Trade Policy Review BodyCouncil Implementing Decision (EU) 2017/818 of 11 May 2017 setting out a Recommendation for prolonging temporary internal border control in exceptional circumstances putting the overall functioning of the Schengen area at riskCouncil Decision (EU) 2017/859 of 11 May 2017 on the position to be adopted, on behalf of the European Union, within the EEA Joint Committee concerning an amendment to Protocol 31 to the EEA Agreement, on cooperation in specific fields outside the four freedoms (Budget Line 02.03.01 Internal Market and Budget line 02.03.04 Internal Market Governance Tools)Council Decision (EU) 2017/860 of 11 May 2017 on the position to be adopted, on behalf of the European Union, within the EEA Joint Committee concerning an amendment to Protocol 31 to the EEA Agreement, on cooperation in specific fields outside the four freedoms (Budget Line 33.02.03.01)Council Decision (EU) 2017/861 of 11 May 2017 on the position to be adopted, on behalf of the European Union, within the EEA Joint Committee concerning an amendment to Protocol 3 to the EEA Agreement, concerning products referred to in Article 8(3)(b) of the AgreementCouncil Decision (EU) 2017/865 of 11 May 2017 on the signing, on behalf of the European Union, of the Council of Europe Convention on preventing and combating violence against women and domestic violence with regard to matters related to judicial cooperation in criminal mattersCouncil Decision (EU) 2017/866 of 11 May 2017 on the signing, on behalf of the European Union, of the Council of Europe Convention on preventing and combating violence against women and domestic violence with regard to asylum and non-refoulementCouncil Decision (EU) 2017/883 of 11 May 2017 on the position to be adopted, on behalf of the European Union, within the EEA Joint Committee concerning an amendment to Protocol 31 to the EEA Agreement, on cooperation in specific fields outside the four freedoms (Budget Line 12.02.01)Council Decision (EU) 2017/939 of 11 May 2017 on the conclusion on behalf of the European Union of the Minamata Convention on MercuryCouncil Decision (EU) 2017/1368 of 11 May 2017 on the signing, on behalf of the European Union and its Member States, and provisional application of the Third Additional Protocol to the Agreement establishing an association between the European Community and its Member States, of the one part, and the Republic of Chile, of the other part, to take account of the accession of the Republic of Croatia to the European UnionCommission Implementing Decision (EU) 2017/802 of 10 May 2017 not approving PHMB (1600; 1.8) as an existing active substance for use in biocidal products for product-type 5 (Text with EEA relevance. )

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next